The newest Change Maker Chronicle is here! Drug shortages are still impacting patients every day, but together we are pushing forward. See how we’re raising awareness, fostering advocacy, and building resilent drug supply chains to end drug shortages NOW.
The 2025 Angels for Change Impact Report: 5 Years of Change Edition is here. This special mile5tone edition reflects on the progress, partnerships, and patient-centered solutions that shaped our journey and defined our impact in 2025.
Drug shortages affect real patients every single day—making reliable access to medication not just a goal, but a necessity. That’s why we’re proud to champion the patient voice in three important CMS comment letters focused on strengthening a more dependable and resilient drug supply.
At Angels for Change, advocacy is more than a mission—it’s action. By collaborating with leading partners such as the Duke-Margolis Institute for Health Policy, the End Drug Shortages Alliance (EDSA), and the U.S. Pharmacopeia Drug Shortage Task Force, we’re helping drive solutions that are both practical and firmly rooted in the real needs of patients.
The newest Change Maker Chronicle is here! Drug shortages are still impacting patients every day, but together we are pushing forward. See how we’re raising awareness, fostering advocacy, and building resilent drug supply chains to end drug shortages NOW.
Angels for Change is proud to announce a major Project PROTECT milestone: our partner Fagron Sterile Services is now fully production-ready with new U.S. capacity for Sterile Water for Injection—a critical component used in countless injectable medicines.
This marks the second successful Project PROTECT collaboration with Fagron, following earlier investments that helped protect patients during the IV fluid shortage in 2024. By investing in domestic manufacturing infrastructure, we’re strengthening the resilience of the U.S. drug supply and protecting patients before shortages occur.
We don’t just talk about ending drug shortages—we’re creating solutions that build onshore readiness, strengthen supply chains, and protect patient access to lifesaving medicines.
Angels for Change today announced that the Mark Cuban Cost Plus Drug Company has completed the Preparation and Protective phases of Project PROTECT for Carboplatin Injection and Methotrexate Injection—two essential oncology medicines currently in nationwide shortage. This milestone strengthens onshore readiness and improves supply availability for patients across the United States.
New from Angels for Change: the launch of our Policy Lab.
The A4C Policy Lab brings together patients, clinicians, policymakers, and industry leaders to turn frontline experience into actionable policy solutions that address drug shortages at their root.
Last week on January 29th, 2026, Angels for Change convened a sold-out National Policy Lab on Capitol Hill in the historic Kennedy Caucus Room to tackle one of the most urgent issues in healthcare: the U.S. drug shortage crisis.
Angels for Change is translating patient harm into real-world policy solutions. This Policy Lab wasn’t a conference — it was a working session focused on collaboration, candor, and outcomes, with patients at the center of every solution.
Angels for Change — 2025 Year in Review
From supporting patients through dozens of different shortage crisis to launching a first-of-its-kind oncology resiliency program to shaping national policy conversations, 2025 was a year of bold action and patient-driven progress.
Together with partners across healthcare, government, and industry, we:
Protected patients during critical drug shortages
Launched Project GOLD to proactively safeguard cancer care
Protected 4 addition essential medicines for the American people with Project PROTECT
Elevated patient voices in policy and supply chain reform
Built momentum toward a more resilient medicine supply system
See how collaboration, transparency, and patient leadership are driving lasting change.
The newest Change Maker Chronicle is here! This issue shares powerful stories, advocacy updates, and partner impact. Inside you will find ongoing efforts to end drug shortages and improve patient access. Discover key milestones and see how support drives meaningful change.
Angels for Change’s Project PROTECT has taken a significant step to strengthen preparedness for a lifesaving medicine, magnesium sulfate. In partnership with STAQ Pharma, magnesium sulfate is now ready for on-demand production, reinforcing resilience for a medicine essential to protecting mothers and newborns during emergencies and supply strain. This proactive readiness ensures patients receive vital treatment without delay.
Angels for Change Honors 2025 Change Maker of the Year
Angels for Change has named Vimala Raghavendran, Vice President at the U.S. Pharmacopeia (USP), as the 2025 Change Maker of the Year. Raghavendran created the groundbreaking Medicine Supply Map, a first-of-its-kind tool used nationwide to uncover vulnerabilities in the medicine supply chain and prevent drug shortages.
Her innovation has powered lifesaving work at A4C and beyond — strengthening access to critical medicines and protecting patients.
The newest Change Maker Chronicle is here! This issue shares powerful stories, advocacy updates, and partner impact. Inside you will find ongoing efforts to end drug shortages and improve patient access. Discover key milestones and see how support drives meaningful change.
Angels for Change announces Fagron Sterile Services US (FSS) has been awarded a 2025 Project PROTECT grant to produce sterile water for injection (SWIFI), a critical component in the preparation of injectable medications and currently listed on the FDA’s drug shortage list.
2025 Drug Shortage Guardian Award Honors Federal Heroes Who Saved Lives During IV Fluid Crisis
Agencies recognized by patient advocacy organization, Angels for Change, for swift action and lifesaving logistics following hurricanes Helene and Milton.
Angels for Change (A4C) announces its 2024 Change Maker of the Year Award , Lindsey Thomas, Senior Vice President of Marketing at Fresenius Kabi USA. Lindsey was recognized for her exceptional leadership, collaborative spirit, and unwavering commitment to patient care, particularly in addressing the critical chemotherapy drug shortages during 2023 and 2024.
Angels for Change is proud to announce a significant milestone in Project PROTECT. Fagron Sterile Services US (FSS), a recipient of the 2023 Project PROTECT grant and a leader 503B outsourcing, has completed the Preparation and Protective phases for preservative-free Dextrose 70% injection solution. The significance of this achievement is highlighted by the recent flooding at Baxter's North Cove manufacturing site due to Hurricane Helene, which prompted the U.S. Food and Drug Administration to include Dextrose on its drug shortage list as of October 12, 2024. The strategic preparations made through Project PROTECT, Dextrose will remain accessible to vulnerable patients, especially PICU and NICU babies, amid anticipated supply chain disruptions.
Angels for Change is proud to announce the continued expansion of Project PROTECT, a pioneering initiative to mitigate drug shortages by building an onshore resilient and redundant supply of vulnerable essential medicines.
Read 2 new warrior stories from patients in a drug shortage crisis and explore how Angels for Change is boldly working with Champions and the Cancer Moonshot team, advocating during a Capitol Hill briefing, expanding of our team to build the supply chain of the future.
Angels for Change, the nation’s only nonprofit, patient advocacy organization dedicated to ending drug shortages, announces expansion of their team to three employees with the addition of a Chief Operating Officer (COO).
Angels for Change, a nonprofit organization dedicated to ending drug shortages, hosted the fifth annual SummitONE conference on July 8 and 9 at Fresenius Kabi’s U.S. headquarters in Lake Zurich, Illinois. SummitONE is the only annual conference that gathers supply chain leaders, drug shortage experts, policy makers, and patients to discuss solutions to end drug shortages.
Leap into our latest Issue 9, Quarter 2, 2024 of The Changemaker Chronicle!
Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization’s 2024 Drug Shortage Guardian Award to Fresenius Kabi (USA), a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition headquartered in Lake Zurich, IL.
